BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 26310586)

  • 1. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.
    Roach RE; Helmerhorst FM; Lijfering WM; Stijnen T; Algra A; Dekkers OM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011054. PubMed ID: 26310586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
    Dragoman M; Curtis KM; Gaffield ME
    Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
    Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
    Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR; Ory H
    Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
    Lopez LM; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006133. PubMed ID: 24788670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
    Lopez LM; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006133. PubMed ID: 22513937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of hormonal contraceptives among women with migraine: A systematic review.
    Tepper NK; Whiteman MK; Zapata LB; Marchbanks PA; Curtis KM
    Contraception; 2016 Dec; 94(6):630-640. PubMed ID: 27153744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular events associated with different combined oral contraceptives: a review of current data.
    Hannaford P
    Drug Saf; 2000 May; 22(5):361-71. PubMed ID: 10830253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
    Lopez LM; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31711271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined oral contraceptives: venous thrombosis.
    de Bastos M; Stegeman BH; Rosendaal FR; Van Hylckama Vlieg A; Helmerhorst FM; Stijnen T; Dekkers OM
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD010813. PubMed ID: 24590565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal contraceptives and arterial disease: an epidemiological update.
    Plu-Bureau G; Hugon-Rodin J; Maitrot-Mantelet L; Canonico M
    Best Pract Res Clin Endocrinol Metab; 2013 Feb; 27(1):35-45. PubMed ID: 23384744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 20 µg versus >20 µg estrogen combined oral contraceptives for contraception.
    Gallo MF; Nanda K; Grimes DA; Lopez LM; Schulz KF
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD003989. PubMed ID: 23904209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 20 µg versus >20 µg estrogen combined oral contraceptives for contraception.
    Gallo MF; Nanda K; Grimes DA; Lopez LM; Schulz KF
    Cochrane Database Syst Rev; 2011 Jan; (1):CD003989. PubMed ID: 21249657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic stroke and myocardial infarction with hormonal contraception.
    Lidegaard Ø; Løkkegaard E; Jensen A; Skovlund CW; Keiding N
    N Engl J Med; 2012 Jun; 366(24):2257-66. PubMed ID: 22693997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives and myocardial infarction: results of the MICA case-control study.
    Dunn N; Thorogood M; Faragher B; de Caestecker L; MacDonald TM; McCollum C; Thomas S; Mann R
    BMJ; 1999 Jun; 318(7198):1579-83. PubMed ID: 10364115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 20 microg versus >20 microg estrogen combined oral contraceptives for contraception.
    Gallo MF; Nanda K; Grimes DA; Lopez LM; Schulz KF
    Cochrane Database Syst Rev; 2008 Oct; (4):CD003989. PubMed ID: 18843653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.
    Horton LG; Simmons KB; Curtis KM
    Contraception; 2016 Dec; 94(6):590-604. PubMed ID: 27263039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception.
    Gallo MF; Nanda K; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003989. PubMed ID: 15846690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestin-only pills for contraception.
    Grimes DA; Lopez LM; O'Brien PA; Raymond EG
    Cochrane Database Syst Rev; 2013 Nov; (11):CD007541. PubMed ID: 24226383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.
    Mann JI
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.